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Sis1 is an essential yeast Type II Hsp40 protein that
assists cytosolic Hsp70 Ssa1 in the facilitation of pro-
cesses that include translation initiation, the preven-
tion of protein aggregation, and proteasomal protein
degradation. An essential function of Sis1 and other
Hsp40 proteins is the binding and delivery of non-native
polypeptides to Hsp70. How Hsp40s function as molecu-
lar chaperones is unknown. The crystal structure of a
Sis1 fragment that retains peptide-binding activity sug-
gests that Type II Hsp40s utilize hydrophobic residues
located in a solvent-exposed patch on carboxyl-terminal
domain I to bind non-native polypeptides. To test this
model, amino acid residues Val-184, Leu-186, Lys-199,
Phe-201, Ile-203, and Phe-251, which form a depression
in carboxyl-terminal domain I, were mutated, and the
ability of Sis1 mutants to support cell viability and func-
tion as molecular chaperones was examined. We report
that Lys-199, Phe-201, and Phe-251 are essential for cell
viability and required for Sis1 polypeptide binding ac-
tivity. Sis1 I203T could support normal cell growth, but
when purified it exhibited severe defects in chaperone
function. These data identify essential residues in Sis1
that function in polypeptide binding and help define the
nature of the polypeptide-binding site in Type II Hsp40
proteins.
Hsp40s represent a structurally diverse family of co-chaper-
ones that function with Hsp70 to facilitate cellular processes
that include protein folding, the suppression of protein aggre-
gation, endocytosis, protein translocation across membranes,
signal transduction, DNA replication, protein degradation, and
prion propagation (1–4). Hsp70 facilitates these processes by
utilizing energy derived from ATP hydrolysis to bind and re-
lease regions of proteins that exhibit aspects of non-native
structure (5–7). Hsp40s function by regulating the Hsp70 ATP
hydrolytic cycle (8, 9) and by acting as molecular chaperones
that bind and target non-native proteins to the peptide-binding
site of Hsp70 (10, 11). To regulate Hsp70 ATPase activity
Hsp40 proteins utilize a conserved region, which was identified
in Escherichia coli DnaJ and is termed the J-domain (12, 13).
The J-domain, found in all Hsp40s, is around 70 amino acids in
length and contains a conserved HPD tripeptide that is the
signature motif of this protein family (14). The NMR structure
of the J-domain shows it to contain four -helical regions with
the HPD motif being located in a loop that connects Helix II
and Helix III (15–17). How the J-domain regulates Hsp70
ATPase activity is not entirely clear, but a surface formed by
helix II and the HPD motif is proposed to bind a cleft at the
base of the Hsp70 ATPase domain and thereby stimulates ATP
hydrolysis (18–20). Energy derived from ATP hydrolysis then
drives a conformational change in Hsp70 that is proposed to
involve the closure of a lid structure that covers the peptide-
binding groove and stabilizes Hsp70-peptide complexes (6, 21).
How Hsp40s function as molecular chaperones to bind and
deliver non-native proteins to Hsp70 is not well established
(23). The study of the mechanism for Hsp40 chaperone function
is complicated by the fact that Type I, II, and III Hsp40s are not
functionally equivalent (24–28). Biochemical studies with pu-
rified Type I Hsp40s such as E. coli DnaJ, human Hdj-2, and
yeast Ydj-1 demonstrate that these proteins function as chap-
erones independent of Hsp70 to suppress protein aggregation
(11, 29). On the other hand, Type II Hsp40s such as human
Hdj-1 and yeast Sis1 appear to be less efficient as chaperones
and need to act with Hsp70 to suppress protein aggregation
(27, 30). Type III Hsp40s do not appear capable of suppressing
protein aggregation or facilitating protein folding and, there-
fore, may not function as molecular chaperones (2). Differences
in the structures of Type I, II, and III Hsp40s appear to account
for the differences in chaperone activity exhibited by these
co-chaperone proteins. Type I Hsp40s are modeled after DnaJ
and contain a J-domain, a Gly and Phe (G/F)-rich region, a zinc
finger-like domain, and a conserved carboxyl-terminal domain
(CTD).1 Biochemical and genetic studies suggest that Type I
Hsp40s utilize the zinc finger-like region and portions of CTD
to bind non-native proteins (31–33). Type II Hsp40s contain the
J-domain, G/F-rich region, and the CTD but lack the zinc
finger-like region, which is replaced in part by a Gly and Met
(G/M)-rich region (2). Biochemical and genetic studies suggest
that the G/F region and portions of the conserved carboxyl
terminus enable Type II Hsp40s to function as chaperones (4,
27, 34). Type III Hsp40s contain the J-domain and other spe-
cialized structures that enable them to bind specific proteins,
nucleic acids, and insert into intracellular membranes (2).
Thus, Hsp40s have evolved to contain different types of
polypeptide-binding domains, and this structural divergence
enables them to direct Hsp70 to bind a broad range of
substrates.
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To investigate the mechanism for the chaperone function of
Type II Hsp40s, we utilized the yeast Sis1 protein as a model
protein (25). Sis1 is an essential 352-amino acid residue protein
that functions in the cytosol with members of the Hsp70 Ssa
family (27, 35). Biochemical studies show that the polypeptide
binding activity of Sis1 is retained by a fragment of the protein
that contains residues 171–352 (Sis1-(171–352)) (27). Consist-
ent with these data, genetic studies have demonstrated that
the CTD of Sis1 carries out functions that are essential to
support cell viability (36). However, the mechanism by which
Sis1 binds and delivers non-native polypeptides to Hsp70 is not
clear.
Insight into the nature of the Sis1 peptide-binding site was
provided by the crystal structure of Sis1-(171–352), which re-
veals that CTD of Sis1 forms a crystallographic homodimer
that has a wishbone-like structure (37). Sis1-(171–352) mono-
mers have an elongated shape and contain two barrel-like
domains, CTDI and CTDII, and a C-terminal dimerization
motif that correspond to residues 180–255, 260–329, and 330–
352, respectively (37). Deletion of the dimerization domain of
Sis1 reduces its ability to help Hsp70 refold luciferase (37), but
monomeric Sis1 can still support the growth of yeast (36). Thus,
Sis1 can carry out its essential functions as a monomer, and
contrary to a previous suggestion (23), the dimerization domain
is not likely to play a direct role in polypeptide binding.
To bind non-native polypeptides, chaperone proteins typi-
cally utilize regions enriched in solvent-exposed hydrophobic
amino acid side chains (38). Analysis of the Sis1-(171–352)
structure revealed the existence of a hydrophobic patch of
amino acids located on the surface of domain I, which was
predicted to participate in Sis1 chaperone function (37). To test
this model, we carried out a mutational analysis of residues
present in the hydrophobic patch in CTDI of Sis1. The results
reported herein demonstrate that highly conserved residues
within CTDI are essential for cell viability and are required for
Sis1 to bind non-native polypeptides.
MATERIALS AND METHODS
Subcloning and Site-directed Mutagenesis of Sis1—To produce a
vector to drive the overexpression of Sis1 in E. coli, the coding sequence
of Sis1 was amplified from yeast genomic DNA by polymerase chain
reaction (PCR) with the 5-primer, SIS-N (5-ACAGAACTAACCATG-
GTCAAGGAGACAAACT T-3), and the 3-prime primer, SIS-C (5-
TGCTTAGGATCCCTATTAAAAATTTTCATCTAT AGC-3). This PCR
product was then cloned into the NdeI and BamHI sites present in the
polylinker of the E. coli expression vector pET9a (39) to generate
pET9aSis1.
To express Sis1 from a plasmid in yeast under the control of its own
promoter the primers SIS-UN (5-ATGACCATCGATCATCCATCTGT-
TGTCCTGTGAAAAGA-3) and SIS-C were utilized to generate a PCR
fragment that contained bases that were –772 to 1056 from the Sis1
start codon (25). This PCR fragment contains both the Sis1 promoter
and open reading frame and was subcloned into the SpeI and BamHI
sites present in the polylinkers of the centromeric yeast expression
plasmids pRS314 and pRS315 (40) to generate pRS314Sis1 and
pRS315Sis1.
To construct the Sis1 point mutants characterized in this study (see
Fig. 2), a 4-primer PCR-based mutagenic protocol was utilized (41).
Briefly, the primers, SIS1-N and SIS1-C were employed in combination
with a set of internally overlapping mutagenic primers to generate PCR
products that contained a single point mutation in Sis1. The mutated
Sis1 PCR products were then digested with StuI and BamHI to gener-
ate a DNA fragment that contained bases 148–1056 of Sis1.
pET9aSIS1, pRS314Sis1, and pRS315SIS1 were then digested with
StuI and BamHI, and the mutated and digested Sis1 PCR fragments
were utilized to replace the region of the wild-type Sis1 open reading
frame present in these plasmids that corresponded to bases 148 to 1056.
Purification of Hsp70 Ssa1 and Sis1—Yeast Hsp70 Ssa1 was purified
from yeast strain MW141 (42) grown in YP medium containing 2%
galactose to an A600 of 3. Hsp70 Ssa1 was then purified using ATP-
agarose, ion exchange, and hydroxyapatite chromatography as de-
scribed previously (9). Wild-type and mutant Sis1 were overexpressed
in E. coli BL21(DE3)pLys by induction with 0.5 mM isopropyl-1-thio--
D-galactopyranoside followed by growth for 3 h at 30 °C. Purification of
Sis1 was then carried out by ion exchange and hydroxyapatite chroma-
tography as described previously (27). Purified proteins were stored on
ice or at –80 °C prior to use.
Assays for Sis1 Protein Folding and ATPase Regulatory Activity—
The ability of Sis1 to cooperate with Hsp70 Ssa1 to facilitate the
refolding of chemically denatured luciferase was monitored as described
previously (27). The ability of Sis1 to stimulate the ATPase activity of
Hsp70 Ssa1 was monitored by thin layer chromatography with polyeth-
yleneimine-cellulose plates as previously described (9).
Limited Proteolysis of Purified Sis1—Purified Sis1 (0.3 mg/ml) was
incubated at 30 °C for 1 h. in 30 ml of buffer (10 mM Hepes, pH 7.4, 150
mM KCl, and 5 mM DTT) that was supplemented with proteinase K
(0.01–1.0 mg/ml). Digestions were terminated by the addition of 0.5 mM
phenylmethylsulfonyl fluoride, and samples were immediately added to
SDS-PAGE sample buffer and run out on 12.5% SDS-PAGE. Previous
studies have demonstrated that the proteolytic products liberated
from Sis1 to be a 21-kDa band that corresponds to residues 171–352
and a pair of 7–9-kDa bands that represent fragments containing the
J-domain (27).
Assay for the Binding of Sis1 to Non-native Polypeptides—To com-
pare the peptide binding activity of Sis1 and the Sis1 mutants, a
binding assay representing a modified version of the enzyme-linked
immunosorbent assay (ELISA) method for detecting complex formation
between DnaJ and its substrates was established (43). The assay is
based on the ability of purified Sis1 to bind non-native proteins immo-
bilized on the surface microtiter plate wells with the retained protein
being detected via ELISA. To immobilize firefly luciferase in the wells
of microtiter plates, it was first chemically denatured by incubation at
5 mg/ml in 3 M guanidine HCl, 25 mM Hepes, pH 7.4, 50 mM KCl, 5 mM
MgCl2, and 5 mM DTT for 1 h at room temperature. Then, 0.2 mg of
denatured luciferase-made 0.1 M NaHCO3 (pH 8.6) was added to wells
and incubated for 30 min at 25 °C. Dot blot analysis demonstrated that
under these conditions more than 90% of the added luciferase was
retained in the wells. When the immobilization reaction was complete,
wells were washed twice with PBS (50 mM phosphate, pH 7.4, 150 mM
NaCl) and then blocked with 150 l of 0.5% bovine serum albumin in
PBS for 30 min. Wells were then washed three times with PBST (PBS
containing 0.05% Tween 20). Sis1 or Sis1 mutants were then added to
the wells in PBST supplemented with 0.2% BSA (PBST/BSA). After a
1-h incubation at 25 °C, the wells were washed five times with PBST.
-Sis1 rabbit polyclonal sera in 50 ml of PBST/BSA was added to the
wells at a 1:5000 dilution and incubated for 1 h at 25 °C. Wells were
washed five times, and then goat anti-rabbit horseradish peroxidase
secondary antibody (1:5000 dilution in 50 ml PBST/BSA) was added,
and incubations were carried out for 45 min. After five washes, perox-
idase substrate solution was added to each well, and color formation
was determined using microplate reader (Bio-Rad) set at 415 nm. Per-
oxidase substrate solution was prepared immediately prior to use by
mixing 36 l of 30% H2O2 and 21 ml of filtered ABTS stock solution (22
mg of ABTS/100 ml of 50 mM sodium citrate, pH 4.0).
Results from control experiments demonstrated that Sis1 could be
detected via ELISA over a 0.1 to 100 ng range of concentrations. In
addition, we demonstrated via Western blot that all of the Sis1 mutants
exhibited the same immunoreactivity to -Sis1 as to Sis1.
In experiments where reduced -lactalbumin (LA) was utilized as the
immobilized substrate of Sis1 the following protocol was employed to
generate this substrate. Bovine -LA (type III, Ca2-depleted; Sigma)
at 5 mg/ml was incubated in 10 mM DTT, 0.1 M Tris (pH 8.7), 0.2 M KCl,
and 1 mM EDTA for 15 min at °C. Then 0.4 g of reduced LA (R-LA) was
added to the wells of microtiter plates in 0.1 M NaHCO3 (pH 8.6)
supplemented with 5 mM DTT in a volume of 50 l. Complex formation
between immobilized R-LA and Sis1 was then monitored as described
above, except R-LA was maintained in its reduced stated by the addi-
tion of 2 mM DTT to all reaction mixtures.
Assay for the Ability of Sis1 Mutants to Support the Growth of
Yeast—The in vivo function of the Sis1 CTDI mutants was analyzed by
determining whether they could support the growth of a sis1 strain
(MATa ade2-1 his3-11,15 leu2-3,112 ura3-1 trp1-1 ssd1-D2 can1-100
sis1::His3; (25) or a sis1::ydj1 strain (JJ1146;MATa trp1-1 ura3-1
leu2-3,112 his3-11,15 ade2-1 can1-100 met2-D1 lys2-D2 ydj1::His3 sis1::
Leu2 (36). The viability of these respective strains was supported by
Sis1 supplied on the low copy Ura3 plasmid pRS316 (40). To swap
wild-type Sis1 for its mutant forms the plasmid shuffle technique was
utilized (44). The sis1 strain was transformed with wild-type or mu-
tant Sis1 that was supplied on a low copy Leu2 plasmid pRS315 (40).
The sis1::ydj1 strain was transformed with wild-type or mutant SIS1
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that was supplied on a low copy Trp1 plasmid pR314 (40). To counter
select for the Sis1 present on the Ura plasmid transformants were
grown on media that contained 5-fluoroorotic acid (44). Strains were
grown at 25 °C for 7 days, and the plates were then photographed.
Western Blot Analysis of Sis1 Expression—The steady state expres-
sion levels of Sis1 mutants were analyzed by Western blot of yeast
extracts with a rabbit polyclonal Sis1 antibody. Freshly selected strains
were grown in selective media to an A600 of 2. Yeast cells were fixed with
5% trichloroacetic acid for 5 min, and then cell pellets were twice
washed with 80% acetone and resuspended in SDS-PAGE sample
buffer. Lysate proteins (5 mg) were resolved on 12% SDS-PAGE and
then transferred to nitrocellulose membranes.
To examine the influence of wild-type Sis1 expression on the steady
state level of the respective Sis1 mutants, a sis1 strain that harbored
Sis1-His6 on low copy pRS316 was generated. This strain was then
transformed with wild-type and mutant forms of Sis1 on low copy
pRS315 and transformants were selected on synthetic medium that was
devoid of leucine and uracil. When extracts of these strains were pre-
pared and run on 15% gels the Sis1-His6 protein migrated with a slower
mobility than Sis1. This allowed for the visualization of the expression
levels of non-tagged Sis1 mutants and Sis1-His6 in Western blots of cell
extracts.
RESULTS
Identification of Solvent-exposed Hydrophobic Residues in
the Sis1 CTD—To identify regions in Sis1-(171–352) that might
function in peptide-binding, GRASP analysis was utilized to
FIG. 1. The domain structure of Sis1. A, schematic representation of the Sis1 domain structure. The subdomains of Sis1 are labeled as follows:
J, J-domain; G/F, Gly/Phe-rich region; G/M, Gly/Met-rich region; CTD1 and CTD2, carboxyl-terminal domains 1 and 2; DD, dimerization domain.
B, GRASP representation of solvent-exposed hydrophobic residues on the surface of the Sis1-(171–352) crystal structure. Red denotes hydrophobic
regions that are formed by carbon atoms in the side chains of Ala, Ile, Leu, Met, Phe, Pro, and Val. C, GRASP representation of the contours within
the hydrophobic patch located on the surface of CTD1. The colors green, gray, and white denote convex, concave, and planar surfaces, respectively.
The labels denote the solvent-exposed hydrophobic amino acid residues that are present within the patch in single-letter code. D, sequence
alignment of CTD1 from Type II Hsp40 proteins from five different genera of organisms. The Type II Hsp40 from Saccharomyces cerevisiae
corresponds to residues 180–258 from Sis1. Asterisks highlight the position and conservation of the solvent-exposed residues depicted in C. Arrows
and bars labeled B1–5 and A1, respectively, mark the -strands and -helical region within CTD1.
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probe the structure of this fragment for solvent-exposed hydro-
phobic residues (Fig. 1, A and B) and contours (Fig. 1C). This
analysis identified an unoccupied solvent-exposed patch of hy-
drophobic amino acid residues located on CTDI of Sis1 mono-
mers. This patch represented the largest solvent-exposed hy-
drophobic region on the surface of Sis1 and is formed by
residues that are contributed by -strands 1, 2, and 5 (Fig. 1, C
and D). A distinguishing feature of this patch is that it contains
a 5-Å deep depression in which the solvent-exposed surface is
lined by highly conserved residues that are both aliphatic and
aromatic in nature (Fig. 1C). Sequence alignment of CTDI from
Sis1 with similar regions from other Type II Hsp40 proteins
demonstrates that residues Leu-186, Lys-199, Ile-203, and
Phe-251 are 100% conserved (Fig. 1D). Whereas Val-184 and
Phe-201 are found in only 20% of the Type II Hsp40s analyzed.
However, in 80% of the cases a methionine residue has conser-
vatively replaced Phe-201. Thus, CTDI of Sis1 contains a patch
of solvent-exposed residues in which lies a depression that is
primarily lined by conserved hydrophobic amino acids having
the potential to be involved in substrate binding.
Sis1 CTDI Mutants Exhibit Defects in Protein Folding Ac-
tivity—To determine whether the surface-exposed residues
that form the hydrophobic patch on CTDI are involved in Sis1
chaperone function, a series of point mutants was constructed
(Fig. 2). Then we examined the ability of purified forms of these
Sis1 mutants to cooperate with Hsp70 Ssa1 in the refolding of
chemically denatured luciferase (Fig. 2, A and B). When paired
with Hsp70 Ssa1, Sis1 K199A, F201H, I203T, and F251S ex-
hibited 70–90% less folding activity than Sis1. In contrast, the
protein folding activity of Sis1 V184T and L86Q was similar to
that of Sis1. These data demonstrate that Lys-199, Phe-201,
Ile-203, and Phe-251 are important for Sis1 to function as a
co-chaperone of Hsp70 Ssa1. However, Val-184 and Leu-186 do
not appear to be critical for Sis1 to function in the refolding of
luciferase.
Sis1 CTDI Mutants Can Stimulate Hsp70 Ssa1 ATPase Ac-
tivity—For Hsp40 proteins to facilitate luciferase folding they
must be able to interact with Hsp70 to stimulate its ATPase
activity. To assure that the Sis1 CTDI mutants that exhibited
defects in chaperone function retained the ability to interact
with Hsp70, their ability to stimulate the ATPase activity of
Hsp70 Ssa1 was examined (Fig. 3A). All of the Sis1 mutants
tested were observed to stimulate the ATPase activity of Hsp70
Ssa1 to the same degree as Sis1. Thus, defects in regulation of
Hsp70 ATPase activity do not appear to be responsible for the
observed reductions in the protein folding activity of the Sis1
CTDI mutants.
To rule out the possibility that mutation of CTDI caused Sis1
to misfold, thereby hindering its ability to function as a chap-
erone, we evaluated the folded state of the different Sis1 CTDI
mutants. This was accomplished by analyzing the pattern of
proteolytic fragments that were liberated by limited digestion
of the respective Sis1 mutants by proteinase K. Proteinase K
digestion of Sis1 generates proteolytic fragments that corre-
spond to the J-domain and Sis1-(171–352) (Fig. 3B). When the
protease resistance of purified Sis1 K199A, F201H, and I203T
mutants were compared with that of Sis1, we observed no
difference in the pattern of fragments formed. In contrast, Sis1
F251S was more sensitive to digestion than the other mutants.
The crystal structure of Sis1-(171–352) shows that Phe-251 is
located on B5 and forms the base of the depression identified in
Sis1 CTDI. Phe-251 is positioned between B1 and B3 and is
predicted to promote interactions between these -strands that
stabilize the Sis1 structure (37). Therefore, the observation
that Sis1 F251S exhibits increased sensitivity to proteinase K
was not surprising. However, this result does hinder our ability
to make interpretations as to whether Phe-251 is directly in-
volved in Sis1 chaperone function or simply plays a structural
role. Nonetheless, defects in the chaperone function observed
for Sis1 K199A, F201H, and I203T do not appear to be a result
of their defective folding.
Sis1 CTDI Mutants Exhibit Defects in Polypeptide Bind-
ing—To test whether the Sis1 CTDI mutants exhibited defects
in polypeptide binding, we utilized an ELISA to analyze their
ability to form stable complexes with denatured luciferase (D-
Luc; Fig. 4A). To validate this ELISA, Sis1 was demonstrated
to bind the D-Luc that was immobilized in the wells of micro-
titer plates in a concentration-dependent manner. Then the
inclusion of soluble D-Luc, but not native luciferase, in reac-
tions was shown to competitively block Sis1 binding to immo-
bilized D-Luc. Thus, ELISAs represent a valid tool to monitor
complex formation between Sis1 and non-native substrates.
Next, we compared the ability of Sis1 and the CTDI mutants
FIG. 2. Cooperation of Sis1 CTDI mutants with Hsp70 Ssa1 in
the refolding of chemically denatured luciferase. A, kinetics of
luciferase refolding by purified Hsp70 Ssa1 and Sis1 CTDI mutants.
Firefly luciferase (0.04 M) was denatured with guanidinium HCl and
incubated in protein folding buffer (25 mM Hepes, pH 7.4, 50 mM KCl,
5 mM MgCl2, and 1 mM ATP) that contained 0.6 M Ssa1 and 1 M Sis1
or the indicated Sis1 CTDI mutant. Incubations were at 30 °C, and at
the indicated times, aliquots of reactions mixtures were removed and
assayed for luciferase activity with a Turner TD20/20 luminometer.
Maximal rates of luciferase refolding by Hsp70 Ssa1 and Sis1 occur
under the experimental conditions described elsewhere (33). When the
Sis1 CTDI mutant proteins were added to reactions at up to 5 M, we
did not observe an increase in rates of luciferase refolding (data not
shown). Luciferase activity is expressed in arbitrary units. B, quanti-
tation of the relative amounts of luciferase refolded by different Sis1
CTDI mutants. Luciferase activity in reaction mixtures that contained
Hsp70 Ssa1 (0.6 M) and the indicated Sis1 CTDI mutant (1.0 M) was
measured after 60 min of incubation at 30 °C. Values are averages of
the indicated number of individual experiments  S.D. and are ex-
pressed as a percentage of the luciferase activity observed when it was
refolded by Hsp70 Ssa1 and Sis1.
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to bind immobilized D-Luc (Fig. 4, B and C). Sis1 and the Sis1
V184T and L186Q mutants produced similar binding curves. In
contrast, when compared with Sis1, the binding of Sis1 K199A,
F201H, I203T, and F251S to D-Luc was reduced from 50 to
75%.
To examine the role of CTDI in the binding a different
substrate protein, complex formation between the Sis1 CTDI
mutants and a calcium-depleted and reduced form of -lactal-
bumin was measured (Fig. 5). R-LA differs from D-Luc in that
it has a partially collapsed or molten globule conformation that
exposes a number of hydrophobic surfaces and is thought to
resemble a late-stage protein-folding intermediate (45, 46). Re-
sults from control experiments presented in Fig. 5A demon-
strate that Sis1 can bind immobilized R-LA in a dose-depend-
ent and conformation-specific manner. Results presented in
Fig. 5, B and C, show that Sis1 V184T and L186Q bind to R-LA
with the same efficiency as Sis1. In contrast, the ability of Sis1
K199A, F201H, I203T, and F251S to bind R-LA was reduced
from 60 to 85%.
Data obtained from assays that monitor complex formation
between Sis1 and two different substrates provide direct evi-
dence that conserved residues lining the hydrophobic depres-
sion on CTDI are required for polypeptide binding. These data
suggest that the Sis1 CTDI mutants are defective in luciferase
folding because they have a reduced capacity to bind denatured
luciferase.
Sis1 CTDI Mutants Are Unable to Support Cell Growth—To
carry out its essential functions Sis1 requires its J-domain and
regions within CTDI (34, 36). Loss of Sis1 CTDI function can be
complemented partially by the presence of Ydj1 in the yeast
FIG. 3. Characterization of the Sis1 CTDI mutants folded state
and ability to stimulate Hsp70 Ssa ATPase activity. A, stimulation
of Ssa1 ATPase activity by CTDI mutants. Purified Hsp70 Ssa1 (0.5 M)
and the indicated form of Sis1 (1 M) were incubated with [32P]ATP at
30 °C for 10 min. Under these conditions maximal stimulation of Hsp70
Ssa1 ATPase activity is observed. ADP formation was then determined
by thin layer chromatography on polyethyleneimine-cellulose plates
and scintillation counting. Rates shown represent the average of three
independent trials  S.D. WT, wild type. B, sensitivity of Sis1 and the
Sis1 CTDI mutants to protease digestion. Limited proteolysis of Sis1
(0.3 mg/ml) by proteinase K (PK) was performed at 30 °C for 1 h with
indicated concentrations of proteinase K. Digested samples were ana-
lyzed on 12.5% SDS-polyacrylamide gel electrophoresis and stained
with Brilliant Blue R-250. Arrows denote the position of Sis1p-(171–
352) and two different Sis1 fragments that contain the J-domain.
FIG. 4. Binding of Sis1 mutants to chemically denatured lucif-
erase. A, binding of Sis1 to D-Luc. Firefly luciferase (5 mg/ml) was
denatured in 3 M guanidine hydrochloride for 1 h. Then 0.2 g of D-Luc
was immobilized in the wells of microtiter plates (see “Materials and
Methods” for details). After luciferase immobilization, Sis1 was added
to wells at concentrations that ranged from 12 to 100 nM. Incubations
were carried out in a reaction buffer composed of PBST supplemented
with 0.2% BSA for 30 min at 25 °C. In competition experiments, the
Sis1 concentration was held at 50 nM, and native luciferase or D-Luc
was added at the designated concentrations. Retention of Sis1 in wells
was detected using a rabbit anti-Sis1 serum and goat anti-rabbit cou-
pled to horseradish peroxidase with color formation being detected at
415 nm. Color formation was linear between 0.1 and 0.6 OD units. B,
comparison of the binding activity of Sis1 and Sis1 CTDI mutants to
D-Luc (100 nM). C, quantitation of the binding of Sis1 CTDI mutants
(100 nM) to immobilized D-Luc (100 nM). Values are expressed as a
percentage of wild-type Sis1 (WT) binding.
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cytosol (34, 36). Thus, we examined the importance of residues
that line the hydrophobic depression in Sis1 for its in vivo
functions by determining the ability of the CTDI mutants to
support the growth of sis1 and sis1ydj1 strains (25, 36).
Sis1 K199A, F201H and F251S were not capable of supporting
the growth of a sis1ydj1 strain (Fig. 6A). Growth defects
were also observed when Sis1 F201H and F251S were asked to
support the life of a sis1 strain, but these strains remained
viable (Fig. 6A). Sis1 strains that harbored Sis1 K199A and
Sis1 I203T grew normally (Fig. 6A). Thus, it appears the pres-
ence of Ydj1 in the cytosol of the sis1 strains complements the
defects in the chaperone function of Sis1 K199T and F201H and
allows sis1 strains that harbor these mutants to grow. How-
ever, in the absence of Ydj1, the residues Lys-199, Phe-201, and
Phe-251 become essential for Sis1 to maintain cell viability.
FIG. 5. Binding of Sis1 CTDI mutants to reduced bovine -lac-
talbumin. A, interaction of Sis1 with immobilized R-LA. The fully
reduced form of -lactalbumin (0.4 g) in a 50-ml volume was immobi-
lized in microplate wells. The binding of Sis1 to R-LA was then moni-
tored via the method described for D-Luc in the legend to Fig. 4, except
R-LA was maintained in its reduced molten globule form by the addi-
tion of 2 mM DTT to binding reactions. B, comparison of the binding of
the Sis1 CTDI mutants to R-LA (100 nM). C, quantitation of the binding
of different forms of Sis1 CTDI mutants (100 nM) to immobilized R-LA
(100 nM). Values are expressed as a percentage of wild-type Sis1 (WT)
binding activity when 100 nM of Sis1 was added.
FIG. 6. Growth phenotypes of Sis1 CTDI mutants. A, wild-type
(WT) or mutant versions of Sis1 were introduced into a sis1 or sis1
ydj1 strain by the plasmid shuffle technique and selected on media
that contained 5-fluroorotic acid (44). Strains were grown at 25 °C for 7
days, and then the plates were photographed. B, analysis of the expres-
sion levels of the different Sis1 CTDI mutants in the sis1 strain. The
sis1 strain harboring Sis1 or the indicated CTDI mutant was cultured
at 25 °C in selective liquid media to an OD of 2.0. Panels from Western
blots of cell extracts (5 g/lane) from trichloroacetic acid-fixed cells were
then probed with antibody against Sis1, Ydj1, and Hsp70 Ssa1. The
labeling above the lanes denotes the Sis1 CTDI mutant in which steady
state expression level was analyzed. The quantitation below in panel B
represents the ratio of Sis1 CTDI to Sis1 expression. C, co-expression of
Sis1-His6 reduces the steady state expression level of Sis1 F201H and
Sis1 F251S. The sis1 strains that harbored the different Sis1 mutant
alleles were cultured as described above, and the steady state level of
Sis1 expression was probed by Western blot. The mobility of Sis1-His6
and Sis1 on 15% SDS-PAGE gels is denoted.
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Residue Ile-203 in Sis1 was demonstrated to be required for
chaperone function in vitro but was not observed to be essential
in vivo. The simplest explanation of this result is that although
Ile-203 is important for the binding of some substrates, it is not
required for the binding and/or folding of all substrates of Sis1.
The results presented support the conclusion that residues in
CTDI that are required for polypeptide-binding are also essen-
tial in maintaining cell viability.
Expression Levels of Sis1 CTDI Mutants—To assure that the
inability of the Sis1 CTDI mutants to support normal cell
growth was not caused by decreased expression, the steady
state level of the various forms of Sis1 expressed in the sis1
strain were compared by Western blot (Fig. 6B). Sis1 K199A
and I203T were detected at levels near that of Sis1. Interest-
ingly, Sis1 F201H and F251S were detected at levels 10–14
times greater than Sis1. Thus, the Sis1 mutants can be ex-
pressed in yeast, and the growth defects observed do not appear
to result from reduction in protein levels.
Why are the steady levels of Sis1 F201H and F251S ele-
vated? Sis1 is known to autoregulate its own expression, and
the deletion of regions near CTDI causes an induction of Sis1
expression (47). Thus, defects in the chaperone function of Sis1
F201H and F251S may have caused them to lose their ability to
autoregulate their own expression. If this is the case, then the
co-expression of Sis1 along with these mutants should return to
their steady state levels toward normal. Indeed, this was found
to be the case (Fig. 6C). Why the F201H and F251S mutants
are expressed to higher levels than other Sis1 CDTI mutants
such as K199A and I203T, which are also defective in chaper-
one function, is not clear.
Increased expression of Sis1 F201H and F251S could have
dominant negative effects on Hsp70 Ssa1 chaperone action and
thereby give rise to the defective growth observed in the sis1
strains that harbor these mutants. To examine this possibility,
Sis1 F201H and F251S were overexpressed from a high copy
plasmid in a wild-type and ydj1 strain and no alteration in the
growth rates of either was observed (data not shown). These
collective data suggest that mutations in CTDI cause growth
defects in yeast because Sis1 mutants cannot perform their
essential in vivo chaperone functions.
DISCUSSION
The data presented herein support the conclusion that the
Type II Hsp40 chaperone protein Sis1 utilizes conserved resi-
dues that form a hydrophobic depression on CTDI to bind
non-native polypeptides. The function of CTDI in polypeptide
binding was demonstrated through the mutational analysis of
residues Val-184, Leu-186, Lys-199, Phe-201, Ile-203 and Phe-
251, which form a 5-Å deep depression on the surface of this
domain. Mutation of these residues compromised the chaper-
one functions of Sis1 to different degrees; these data are dis-
cussed below. Lys-199, Phe-201, and Ile-203 are all located on
-strand 2 in the Sis1-(171–352) structure. The mutation of
these residues severely compromised the polypeptide binding
and protein folding activity of purified Sis1. Lys-199 is a highly
conserved residue in Type II Hsp40s, but it has a charged
-amino group and therefore would not have been predicted to
function in polypeptide binding. However, the Sis1-(171–352)
structure indicates that the carbon atoms in the side chain of
Lys-199 form a portion of the wall of the 5-Å deep hydrophobic
depression in CTDI. In addition, the charged -amino group of
Lys-199 is bent away from the interior of the hydrophobic
depression and is therefore not predicted to interfere with the
binding of hydrophobic amino acids presented by non-native
protein substrates of Hsp40s (23). Phe-201 is the least con-
served of the residues that line the hydrophobic depression of
Sis1, but nonetheless, the aromatic ring in its side chain has a
large exposed surface in the wall of the depression in Sis1
CTDI. Ile-203 is a highly conserved residue, and the aliphatic
side chain of this residue lies adjacent to the aromatic ring of
Phe-201 on the surface of depression Sis1 CTDI. Thus, Lys-199,
Phe-201, and Ile-203 all lie adjacent to each other in the Sis1
structure, and these three residues appear to form a hydropho-
bic surface that is important for the binding of non-native
polypeptides. A notable observation was that Lys-199 and Phe-
201 are essential for cell viability, but mutation of I203T did
not cause any detectable growth defects. A simple explanation
for this result is that in the absence of the Ile-203 side chain,
the solvent-exposed carbons in Lys-199 and Phe-201 form a
hydrophobic surface that is sufficient for Sis1 to bind its essen-
tial in vivo substrates. However, the chaperone functions of the
I203T mutant were clearly compromised because it exhibited
severe defects in the binding of two different model substrates.
F251 is located on -strand 5 and forms the base of the
hydrophobic depression on CTDI (37). The Sis1 F251S mutant
could not support the growth of the sis1ydj1 strain and
exhibited a compromised ability to function as a chaperone.
However, purified Sis1 F251S was less resistant to protease
digestion than Sis1. Sis1 F251S appeared to fold properly but
may be less stable than Sis1 because Phe-251 is likely to form
contacts between -stands 1 and 2 that help stabilize the struc-
ture of CTDI. Thus, although Phe-251 is essential for Sis1
chaperone function, whether it simply plays a structural role or
actually participates in making contacts with non-native
polypeptides is not clear.
Val-184 and Leu-186 are highly conserved residues and thus
are predicted to be important for the function of Type II
Hsp40s. However, the alteration of Val-184 and Leu-186 did
not have a detectable effect on Sis1 function in vitro or in vivo.
In addition to the results reported herein, we have also con-
structed a V184T,L186Q double mutant, which did not exhibit
any detectable functional defects (data not shown). The results
obtained with the Val-184 and Leu-186 mutants demonstrate
that the aliphatic side chains of Val-184 and Leu-186 can be
mutated to more polar side chains and Sis1 still retains its
chaperone function. Since the mutational analysis of these
residues was not exhaustive, the question of whether or not
Val-184 and Leu-186 are important for Sis1 chaperone function
requires further examination.
Sis1 and Ydj1 both function with Hsp70 Ssa1 in the yeast
cytosol to facilitate different aspects of cellular protein metab-
olism (24, 25). Sis1 and Ydj1 exhibit differences in their ability
to function as chaperones; this observation has been attributed
to the fact that regions of these proteins that are implicated as
polypeptide-binding domains show limited sequence similarity
(27). However, recent genetic studies have shown that the
peptide-binding domains of Sis1 and Ydj1 share overlapping
essential functions and are likely to bind some of the same in
vivo substrates (36). In these aforementioned studies the Craig
group (36) demonstrated that a fragment of Sis1 that contains
the J-domain, G/M region, and CTDI, but not just the J-domain
and G/M region, was sufficient to maintain the viability of a
sis1ydj1 strain. Based on these data and the prediction from
the Sis1-(171–352) structure that CTDI contains a peptide-
binding site, it was concluded that function of the substrate
binding region of Sis1 was required to maintain the viability of
a sis1ydj1 strain. The data we present are in agreement
with these studies, and we have extended them by identifying
essential residues located in CTDI that enable Sis1 to function
in polypeptide binding.
What do the data from the mutational analysis of CTDI on
Sis1 tell us about the general nature of the peptide-binding site
for Type II Hsp40s? The shape and the size of the depression in
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CTDI suggest that this region may only be capable of making
contacts with a single residue from a non-native protein. Ge-
netic data from the Lindquist group (4) suggest that, in addi-
tion to CTDI, other non-essential regions in Sis1 may also be
involved in making contacts with non-native proteins.
Sis1chaperone function is required for the maintenance of the
[RNQ] prion (4). Deletion analysis indicates that both the G/F
region and the CTD are required for Sis1 to modulate the
conformational state of [RNQ] (4). A direct interaction be-
tween the G/F region and [RNQ] has not been demonstrated,
but the data presented suggest that this event does occur.
Thus, regions within CTDI may cooperate with other domains
within Sis1 to chaperone non-native polypeptides.
The structures of a number of polypeptide-binding proteins
have been solved (38). In all of these chaperone proteins, some
form of a solvent-exposed hydrophobic region has been found to
serve as the binding site for non-native polypeptides. The sur-
faces of the peptide-binding domains in these chaperones typ-
ically contain one or more depressions that influence substrate
selectivity (38). Thus, the utilization of a hydrophobic patch on
the surface of Sis1 as a component of its polypeptide-binding
site fits with the general mechanism for chaperone action pre-
viously observed for other protein folding factors. Interestingly,
the architecture and valency of different chaperone proteins
shows a wide degree of variation. For example, Sis1 is a dimer,
and although dimerization is not essential to maintain cell
viability, its appears to increase the efficiency of its chaperone
action (37). Hsp70 differs from Sis1 in that it functions as a
monomer, and access to its peptide-binding groove is regulated
by a lid domain (21). Group I chaperonins such as E. coli GroEL
form a homoheptameric ring that is stacked back-to-back to
form a cylinder with two peptide-binding cavities (6, 48). Each
monomer within the GroEL ring utilizes a set of conserved
hydrophobic residues localized on the apical domain near the
mouth of the cavity to bind regions of non-native proteins that
are as large as hairpin loops (49). Prefoldin is a hexameric
molecular chaperone built from two related classes of subunits
and having the shape of a jellyfish. The body of prefoldin is that
of a double -barrel assembly, and it has six arms that have
long tentacle-like coil-coil domain structures (22). The distal
tips of the coil-coil regions expose hydrophobic surfaces that
enable prefoldin to bind to short segments of non-native pro-
teins (22). Thus, although Sis1 is similar to other chaperones in
that it utilizes a solvent-exposed hydrophobic surface as a
component of its peptide-binding 4site, its homodimeric struc-
ture and clamp-like architecture appear to make it structurally
unique.
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